MR Spectroscopy Findings in Retired Professional Rugby League Players

Grants

Funding Acknowledgements

Andrew J. Gardner, Peter Stanwell, Frances Kay-Lambkin, and Christopher R. Levi have been funded to conduct research into concussion in rugby league through a New South Wales Sporting Injuries Committee - Sports Research & Injury Prevention Scheme Grant, and a Brain Foundation, Australia - Brain Injury Award. Andrew J. Gardner acknowledges sport concussion research fellowship funding from Jennie Thomas, Life Governor of the Hunter Medical Research Institute, and Anne Greaves of the Hunter Medical Research Institute. Ross Zafonte was supported in part by the Harvard Integrated Program to Protect and Improve the Health of NFLPA Members. Grant Iverson and Ross Zafonte acknowledge support from the Mooney-Reed Charitable Foundation and the Heniz Family Foundation-Brain Injury Research Fund at Spaulding Rehabilitation Hospital. Author Disclosure/Conflict of Interest Statement Andrew Gardner has a clinical practice in neuropsychology involving the assessment and management of individuals who have sustained sport-related concussion (including current and former athletes). He has received travel funding from the Australian Football League (AFL) to present at the Concussion in Football Conference in 2013. He has served as a concussion consultant to the Australian Rugby Union (ARU) from July 2016. Grant Iverson, PhD has been reimbursed by the government, professional scientific bodies, and commercial organizations for discussing or presenting research relating to mild TBI and sport-related concussion at meetings, scientific conferences, and symposiums. He has a clinical and consulting practice in forensic neuropsychology involving individuals who have sustained mild TBIs (including athletes). He has received research funding from several test publishing companies, including ImPACT Applications, Inc., CNS Vital Signs, and Psychological Assessment Resources (PAR, Inc.). He is a co-investigator, collaborator, or consultant on grants relating to mild TBI funded by several organizations, including, but not limited to, the Canadian Institute of Health Research, Alcohol Beverage Medical Research Council, Rehabilitation Research and Development (RR&D) Service of the US Department of Veterans Affairs, Vancouver Coastal Health Research Institute, and Roche Diagnostics Canada. Frances Kay-Lambkin is supported by a fellowship from the National Health and Medical Research Council of Australia. She is the subject of publishing contracts with multiple companies, including CCBT Ltd in the EU, Magelan, multiple BCBSs and Cobalt Therapeutics LLC in the US, as well as the NHS in the UK. Although she has received no remuneration to date, she may receive royalties in the future. She has not received any equity or payments related to the work discussed in this manuscript.